In today’s ACT Brief, we examine why the future of AI in trials is a trusted orchestration system rather than a single model, how coordinators rate eSource-enabled workflows, and what a bipartisan bill proposes for reusable trial networks.
|Articles|February 1, 2007
- Applied Clinical Trials-02-01-2007
- Volume 0
- Issue 0
eShowcase: ComplianceWire
Enhancements to workplace planning tool include "what if" scenario capability
Advertisement
Enhancements to workplace planning tool include "what if" scenario capability
EduNeering (Princeton, NJ) has added several functionalities to ComplianceWire, its knowledge management system designed for FDA-regulated businesses. Key enhancements include a workplace planning tool researchers can use to create "what if" scenarios for determining job qualifications, planning for future growth, vacation scheduling, and cross training.
Other new capabilities include electronic sign-in for instructor-lead courses, eliminating paper-based systems, and providing a layer of authentication to monitor attendance and streamline recordkeeping. The new User Group format allows administrators to organize and manage employee qualifications, career goals, and other role-based activities. They can then suggest knowledge criteria and curricula based on employee qualifications.
EduNeering, (609) 627-5300,
Articles in this issue
over 19 years ago
Health Economics & Analysis in Clinical Developmentover 19 years ago
Electronic Health Records: A Magic Pill?over 19 years ago
Central vs. Local: Rethinking IRBsover 19 years ago
Drowning in the Sea of Regulatory Complianceover 19 years ago
eShowcase: Nextrials and Vitalographover 19 years ago
EHR & EDC: Tomorrow's Technology Todayover 19 years ago
eShowcase: ClearTrial 2.0over 19 years ago
Trial Catastrophe Lends Impetus to Reformover 19 years ago
CDISC & the World of Health Information Technologyover 19 years ago
India: Give or Take?Advertisement
Related to this article
The Faster Clinical Trials Act would create an FDA Center for Clinical Trial Innovation and aims to cut trial costs and enrollment time by at least 30%.
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
In today’s ACT Brief, we examine how sites can avoid both fear-driven and overly aggressive AI adoption, why community-based research needs sustained financial investment, and why patient access matters more than organizational size.
Pacing obesity trial enrollment, anchoring eligibility to stable real-world therapies, and building site and physician relationships improve retention and data quality more than aggressive recruitment or restrictive exclusion criteria do.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination burden or just hands it back to them.
Syneos Health and Optum outline a joint model for trial planning, recruitment and site access, with no financial terms or timelines disclosed.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
2
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
3
Where AI Governance in Clinical Development Falls Short
4
Bipartisan Bill Would Build Reusable Clinical Trial Networks, With a Focus on Rare Disease
5